Briefing: Disabled CDC staff still missing accommodations
Strategic angle: The transformation of organ transplantation, an age to start considering statins, and other health news
Editorial Staff Mar 16
Health
Latest Health stories from Life.
Briefing: New technologies promise to transform organ transplantation. But when?
Strategic angle: Perfusion technology vastly improves organ quality in transplants, but high costs and coverage questions pose barriers in becoming the standard of care.
Editorial Staff Mar 16
Briefing: Opinion: Congress must pass legislation to ensure Medicare covers breakthrough medical technologies
Strategic angle: Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor.
Editorial Staff Mar 16
Briefing: Opinion: I have a genetic mutation linked to ALS. The Trump administration terrifies me
Strategic angle: "Watching my mom die of ALS was one of the most awful things I’ve gone through. I don’t want my children to see me suffer like that."
Editorial Staff Mar 16
Briefing: How STAT would cover ‘The Fugitive’ if its pharma scandal were real
Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real.
Editorial Staff Mar 13
Briefing: Major changes to cardiovascular guidelines suggest taking statins as young as 30
Strategic angle: Cardiology groups say adults as young as 30 should assess cholesterol risk and consider treatment to prevent heart attacks and strokes.
Editorial Staff Mar 13
Briefing: Most Medicare Beneficiaries Affected by Plan Terminations in 2025 Have Robust Medicare Advantage Options in 2026
Strategic angle: Virtually all (98.9%) of the 2.6 million Medicare beneficiaries enrolled in a Medicare Advantage plan that terminated coverage at the end of 2025 have at least one MA-PD available in 2026.
Editorial Staff Mar 13
Epstein’s pal attempts a biotech comeback, and Prasad exits the FDA
On this week's The Readout LOUD podcast: A friend of Jeffrey Epstein attempts a biotech comeback, and (another) Prasad FDA exit.
Editorial Staff Mar 13
Briefing: Trump's Influence on Drug Prices: A Closer Look
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
Editorial Staff Mar 13
Recent Trends in Medicaid Outpatient Prescription Drugs and Spending
This issue brief describes recent trends in the number of Medicaid outpatient prescriptions and the spending on those drugs and examines the implications of recent federal actions on future trends.
Editorial Staff Mar 13
Briefing: Make next year’s flu shots, says FDA committee
Strategic angle: Vaccine skepticism, FDA-authorized vape flavors, and more health news from Morning Rounds
Editorial Staff Mar 13
Poll: Public Worries About Prescription Drug Costs Reach New High
Most Across Political Parties Want Government to Do More to Regulate Prices
Editorial Staff Mar 13
Briefing: Trump is getting more credit than Biden for efforts to lower drug prices
Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx.
Editorial Staff Mar 13
Briefing: FDA move on flavored vapes rattles public health experts
Strategic angle: New FDA guidance suggests mint, coffee, and spice vape flavors could be authorized, raising debate over toxic additives and youth vaping risks.
Editorial Staff Mar 13
Briefing: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality
Strategic angle: The legal battle underscores the complicated questions surrounding how best to evaluate hospital safety.
Editorial Staff Mar 13
Briefing: White House says it’s ‘done’ with vaccines. MAHA begs to differ
Strategic angle: As Trump political advisers try to move on from vaccine policy debates, MAHA movement insiders push back, calling RFK Jr. supporters vital to GOP's success.
Editorial Staff Mar 13
Briefing: Congressional Advisers Call to Rein in Medicare Advantage Spending Amid Industry Pressure
Strategic angle: Lobbying groups supported by insurance companies have criticized the research and promoted their own.
Editorial Staff Mar 12
Briefing: Cancer cells can ‘barf’ proteins onto their cell surface, creating new targets for immunotherapies
Strategic angle: An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors.
Editorial Staff Mar 12
Briefing: The Impact of Gun Violence on Youth Mental Health and Well-Being
Strategic angle: Exposure to gun violence can severely affect the mental health of children and adolescents.
Editorial Staff Mar 12
Briefing: Child and Adolescent Firearm Deaths: National Trends and Variation by Demographics and States
Strategic angle: This brief analyzes the latest youth mortality data from the CDC, revealing alarming trends in firearm-related deaths among children and adolescents.
Editorial Staff Mar 12